Microarray analysis of microrna expression in peripheral blood mononuclear cells of patients with polymyositis and dermatomyositis
Journal of Translational Internal Medicine · 21.05.2024 · 12 (2) · 170-176
DOI: 10.2478/jtim-2022-0055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 21.05.2024. Verfasst von Jia Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Ce…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives MicroRNAs (miRNAs) represent a new class of biomarkers in the context of connective tissue disorders. The miRNA expression profiles in peripheral blood mononuclear cells (PBMCs) of patients with polymyositis (PM) and dermatomyositis (DM) have not been fully elucidated. The objective is to investigate miRNAs expression profile in PBMCs of patients with PM/DM.
Methods
Microarray technology was used to identify differentially expressed miRNAs in PBMCs obtained from 6 untreated PM/DM patients and 3 healthy controls (HCs). TaqMan-based stem-loop real-time PCR detection was used for validation in a cohort of 34 PM/DM patients and 20 HCs.
Results
Microarray analysis revealed 38 differentially expressed miRNAs (24 up-regulated and 14 down-regulated) in PM/DM patients compared to HCs. Four miRNAs (miR-320a, miR-335-3p, miR-34a-5p and miR-454-3p) were chosen for real-time PCR validation. The expression of miR-34a-5p was significantly upregulated in PM/DM group ( P < 0.05). In subgroup analysis, miR-34a-5p was significantly upregulated in interstitial lung disease (ILD) group and DM group ( P < 0.001). The level of SIRT1, a validated target of miR-34a, was significantly lower in PBMCs of PM/DM patients compared with HCs.
Conclusions
MiR-34a-5p may potentially participate in the pathogenesis of PM/DM through SIRT1, and may serve as a potential new biomarker for PM/DM-ILD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of…
- Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
- China-Japan Friendship Hospital, Yinghua East Road, Chaoyang District, Beijing 100029, China.
ORCID-Profile: Linrong He, Chanyuan Wu
Zitieren
APA
Shi, J., Zhou, S., Zhao, J., Xu, D., Huang, H., Li, M., Tian, X., He, L., Wu, C., Wang, Q., Zhao, Y., & Zeng, X. (2024). Microarray analysis of microrna expression in peripheral blood mononuclear cells of patients with polymyositis and dermatomyositis. Journal of Translational Internal Medicine, 12(2), 170-176. https://doi.org/10.2478/jtim-2022-0055
Vancouver
Shi J, Zhou S, Zhao J, Xu D, Huang H, Li M, et al. Microarray analysis of microrna expression in peripheral blood mononuclear cells of patients with polymyositis and dermatomyositis. Journal of Translational Internal Medicine. 2024;12(2):170-176. doi:10.2478/jtim-2022-0055
BibTeX
@article{Shi2024,
author = {Shi, Jia and Zhou, Shuang and Zhao, Jiuliang and Xu, Dong and Huang, Hui and Li, Mengtao and Tian, Xinping and He, Linrong and Wu, Chanyuan and Wang, Qian and Zhao, Yan and Zeng, Xiaofeng},
title = {Microarray analysis of microrna expression in peripheral blood mononuclear cells of patients with polymyositis and dermatomyositis},
journal = {Journal of Translational Internal Medicine},
year = {2024},
volume = {12},
number = {2},
pages = {170--176},
doi = {10.2478/jtim-2022-0055}
}
EUVIMED